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The transition from in situ tumour growth to invasive and
metastatic disease is initially characterized by the potential of the
tumour cells at the primary site to cross tissue barriers and to
invade local tissues. In case of malignant tumours originating from
epithelial tissue, cells in the primary tumour lose adherent cell–cell
interaction, create a pathway through basement membrane and
surrounding stroma, and migrate through the pathway it has
created. Thus, degradation of local extracellular matrix compo-
nents and accompanying cellular movement are particular charac-
teristics associated with invasive tumours.
Studies done in the past decade revealed a unique group of cell
motility factors and that many growth factors and ligands for
receptor tyrosine kinases share motogenic activity (enhancement
of cell motility) (reviewed in Stoker and Gherardi, 1991; Wright
et al, 1993; Levine et al, 1995; Chicoine and Silbergeld, 1997).
Scatter factor was originally identified as fibroblast-derived
motility factor for epithelial cells (Stoker and Perryman, 1985),
while subsequent purification and characterization revealed this
factor to be identical to hepatocyte growth factor (HGF) (Gherardi
et al, 1989; Weidner et al, 1990, 1991; Furlong et al, 1991; Konishi
et al, 1991; Naldini et al, 1991). HGF was originally identified and
cloned as a mitogenic polypeptide for hepatocytes (Nakamura
et al, 1984, 1989; Russell et al, 1984; Miyazawa et al, 1989).
Several growth factors, initially identified as mitogenic poly-
peptides, also affect motility of a wide variety of cells, including
platelet-derived growth factor (PDGF), insulin-like growth
factor-I (IGF-I), IGF-II, basic fibroblast growth factor (bFGF),
transforming growth factor (TGF)-a and TGF-b1 (also see above
reviews). These cell motility factors play important roles in regu-
lating cell movement in physiological and pathological processes,
including embryogenesis, tissue repair, inflammation as well as
tumour invasion (reviewed in Levine et al, 1995; Chicoine and
Silbergeld, 1997; Wehrle-Haller and Weston, 1997; Birchmeier
and Gherardi, 1998).
Migration and invasion of cancer cells are particularly regulated
by cell motility factors which act in autocrine- and/or paracrine-
related manner. Establishment of an autocrine loop of growth
factors is involved in tumorigenic transformation and progression
to malignant cancer cells (Sporn and Roberts, 1985; Ullrich and
Schlessinger, 1990; Wright et al, 1993; Levine et al, 1995; Silletti
and Raz, 1996; Chicoine and Silbergeld, 1997). In addition to
these factors, participation of paracrine factors have been impli-
cated in tumour invasion and malignant progression, as based on
the notion that growth and invasive potentials of carcinoma cells
are influenced through interactions with host stromal cells (van
den Hooff, 1988; Matsumoto et al, 1989; Camps et al, 1990;
Wernert, 1997). HGF is a mesenchymal- (or stromal-)derived
paracrine factor which affects cell growth, cell motility and
morphogenesis of a wide variety of cells, including malignant ones
(Jiang et al, 1993; Matsumoto and Nakamura, 1997; Birchmeier
and Gherardi, 1998). In vitro, HGF stimulates migration or
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invasion of various types of carcinoma cells (Weidner et al, 1990;
Matsumoto et al, 1994; Shibamoto et al, 1994; Jeffers et al, 1996;
Bennett et al, 1997; Inoue et al, 1997; Nakamura et al, 1997; also
reviewed in Jiang et al, 1998) and autonomous activation of
cMet/HGF receptor through the autocrine loop of HGF confers
invasive and metastatic potential of tumour cells (Jeffers et al,
1996).
Oral squamous cell carcinomas are generally malignant tumours,
with invasive and metastatic potentials. We established a distinct
tumour cell line (IF cells) from a patient with oral squamous cell
carcinoma. These IF cells are highly invasive and metastatic when
implanted into athymic mice and thus IF cells retain invasive and
metastatic potential (manuscript in preparation). We hypothesized
that cell motility and invasiveness of IF cells might be regulated by
cell motility factors which act in an autocrine or paracrine manner.
In the present study, we identified paracrine and autocrine cell
motility factors in this tumour cell line. Therefore, IF oral squa-
mous cell carcinoma cells utilize both autocrine- and paracrine-
acting cell motility factors and utilization of these multiple factors
presumably confers invasive and metastatic potential in this malig-
nant oral squamous carcinoma cell line.
MATERIALS AND METHODS
Materials
Mouse monoclonal antibodies against human TGF-a and TGF-b1
were obtained from Calbiochem, Calbiochem-Novabiochem Int.
(Cambridge, MA, USA) and TAGO Products (Burlingame, CA,
USA) respectively. Polyclonal antibody against HGF was
prepared from the serum of a rabbit immunized with human
recombinant HGF and 1 mg ml–1 anti-human HGF IgG completely
neutralized the biological activities of 1 ng ml–1 of human HGF
(Matsumoto et al, 1996). Human recombinant TGF-a was kindly
provided by Genentec (San Francisco, CA, USA) and TGF-b1 was
purified from human platelets (Okada et al, 1989). HGF was
purified from the culture media of Chinese hamster ovary cells
transfected with an expression plasmid containing human HGF
cDNA (Nakamura et al, 1989). Human recombinant interleukin-1
receptor antagonist (IL-1 RA) was obtained from R & D Systems
Inc. (Minneapolis, MN, USA). Antibody against human PDGF
was obtained from Promega (Madison, WI, USA).
Cell culture
IF cells were originally established from a patient with squamous
cell carcinoma of gingiva of the lower jaw. The cells were cultured
in a-modified Eagle’s medium (a-MEM) supplemented with 10%
fetal bovine serum (FBS). MDCK clone 3B (Madin-Darby Canine
Kidney) epithelial cells and GB-d1 human gallbladder carcinoma
cells were kind gifts from Dr R Montesano (University of Geneva)
and Dr H Shimura (Fukuoka University) respectively. MDCK and
GB-d1 cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FBS. Human dermal
and oral fibroblasts were initially allowed to proliferate outward
from tissue obtained during surgery and the cells were cultured in
DMEM supplemented with 10% FBS.
Assay for cell growth and scattering
IF cells were plated at 500 cells cm–2 in 12-well plates in a-MEM
supplemented with 10% FBS and cultured for 24 h. The culture
media was replaced by a-MEM containing 1% FBS and the cells
were cultured in the absence or presence of 10 ng ml–1 HGF, TGF-
a or TGF-b1 for 72 h. The number of cells was counted using a
Coulter counter after dissociation by trypsin.
For cell scattering assay, MDCK or GB-d1 cells were plated at
2.5 ´ 103 cells cm–2 in DMEM containing 10% FBS and cultured
for 24 h. The conditioned medium from IF cells or growth factors
were added, cells were further cultured for 24 h, placed under a
microscope and photographed.
Measurement of HGF production
Human skin or oral fibroblasts were seeded on 48-well plates at a
density of 5 ´ 104 cells cm–2 and cultured for 24 h. After replacing
the media with fresh DMEM supplemented with 1% FBS and
2 mg ml–1 heparin, appropriate amounts of cytokines or the condi-
tioned medium from IF cells was added and the cells were cultured
for 24 h. The concentration of HGF in culture media was
measured by enzyme-linked immunoabsorbent assay (ELISA),
using a kit (Institute of Immunology Co. Ltd, Tokyo, Japan).
In vitro migration assay
Migration of tumour cells was carried out using Transwell
chamber equipped with a filter membrane with 8-mm pores
(Corning Costar Co., Cambridge, MA, USA). Tumour cells were
plated at 5 ´ 104 cells cm–2 in the upper compartment of the
chamber, and cultured for 24 h, fixed in 70% ethanol and stained
with haematoxylin and eosin. The number of cells migrating to the
undersurface of the membrane through the pores was counted, as
viewed microscopically. Six microscopic fields were randomly
selected for cell counting. To examine the inhibitory effects of
specific antibodies on migration of tumour cells, antibodies
against TGF-a, TGF-b and HGF were added at 10 mg ml–1.
In vitro invasion assay
In vitro invasion of tumour cells was measured using the Biocoat
Matrigel Invasion Chamber (Becton Dickinson Labware, Bedford,
MA, USA). In this apparatus, Matrigel basement membrane
components are reconstituted on a filter membrane with 8-mm
pores. The cells were plated at a density of 105 cells cm–2 on the
Matrigel in the upper compartment of the chamber and cultured
for 48 h. The number of cells that invaded the undersurface of the
membrane was counted, as described above. To examine the
extent of invasion of IF cells into collagen gel matrix, the tumour
cells were embedded in collagen gel (Type I Collagen, Nitta
gelatin, Osaka, Japan) at 5 ´ 103 cells ml–1, and cultured for 7 days.
The culture medium was changed every second day.
RESULTS
Production and identification of motility factors from IF
cells
IF cells were established from a lymph node metastasis of poorly
differentiated squamous cell carcinoma which had primarily
developed in the lower jaw. Histologically the tumour was highly
infiltrative and invaded the capsular sheath of metastasized lymph
nodes. When IF cell were subcutaneously implanted in the1710 R Hasina et al
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Figure 1 Cell scattering induced by conditioned medium from IF cells and growth factors. Cell scattering was examined using MDCK renal epithelial cells
(A, B) and GB-d1 gallbladder carcinoma cells (C–J). These cells were cultured in the absence (A, C) or presence of IF-derived conditioned medium (IF-CM)
(B, D), TGF-a (E), TGF-b1 (F), HGF (G), IF-CM + anti-TGF-a IgG (H), IF-CM + anti-TGF-b IgG (I), or IF-CM + anti-HGF IgG (J). IF-CM was added at 50% (v/v)
to these cultures, growth factors were at 10 ng ml–1 and IgGs were at 10 mg ml–1. These antibodies respectively neutralized cell scattering activity of 10 ng ml–1
TGF-a, TGF-b1 and HGF and normal IgG had no effect on cell scattering activity of IF-CM (not shown)Autocrine/paracrine regulation in oral cancer 1711
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athymic mouse, the tumour cells invaded inguinal and axillary
lymph nodes, and visible metastatic nodules were present on lungs
within 4–6 weeks (manuscript in preparation). To determine if IF
human oral squamous cell carcinoma cells produce cell motility
factors, conditioned medium derived from IF cells was added
to monolayer cultures of MDCK cells and GB-d1 gallbladder
carcinoma cells respectively (Figure 1). Addition of conditioned
medium from IF cells induced scattering of both MDCK and
GB-d1 cells (Figure 1 A–D), indicating that IF cells secrete
motility factor(s) bioactive for both MDCK and GB-d1 cells.
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Figure 2 Inhibitory effect of antibodies on stimulatory effect of IF-derived conditioned medium on migration of GB-d1 cells. Migration of GB-d1 cells was
measured using Transwell chamber. (A–D) Appearance of cells which migrated through the membrane with pores. GB-d1 cells were cultured in the absence
(A) or presence of IF-derived conditioned medium (IF-CM) (B), IF-CM + anti-TGF-a IgG (C), IF-CM + anti-TGF-b1 IgG (D). (E) The number of migrated cells.
IF-CM was added at 50% (v/v) to cultures of GB-d1 cells and antibodies (IgGs) against TGF-a, TGF-b1 and HGF (a-TGF-a, a-TGF-b1, a-HGF) were added
at 10 mg ml–1. These antibodies neutralized migration of GB-d1 cells stimulated by 10 ng ml–1 TGF-a, TGF-b1 and HGF (not shown)
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Figure 3 Effects of TGF-a, TGF-b1 and HGF on migration (A) and growth (B) of IF cells. Migration of IF cells was measured using Transwell chamber. For cell
growth assay, IF cells were cultured in the absence or presence of TGF-a, TGF-b1, or HGF for 72 h1712 R Hasina et al
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To identify motility factor(s) derived from IF cells, we asked if
known growth factors and cytokines would induce scattering of GB-
d1 cells (Figure 1). Among various growth factors and cytokines
tested, TGF-a, TGF-b1 and HGF showed scattering effects on GB-
d1 cells (Figure 1 E–G), while PDGF, bFGF, vascular endothelial
cell growth factor, IL-1b, IL-2, IL-6 and tumour necrosis factor-a
did not induce cell scattering (not shown). We therefore examined
effects of antibodies against TGF-a, TGF-b1 and HGF on cell scat-
tering activity in IF-derived conditioned medium. When an antibody
against TGF-a or TGF-b1 was added to the conditioned medium of
IF cells, cell scattering activity in the medium was significantly
inhibited (Figure 1 H, I), whereas anti-HGF antibody had no
inhibitory effect on the cell scattering induced by IF-derived
medium (Figure 1, J). This finding meant that IF-derived cell
motility factors might be TGF-a and TGF-b1.
For further evidence that IF-derived motility factors are TGF-a
and TGF-b1, migration of GB-d1 cells was quantitatively analysed
using a Transwell apparatus (Figure 2). GB-d1 gallbladder carci-
noma cells were seeded on Transwell filter membrane and the
number of cells migrating to the undersurface of the membrane
through 8-mm pores was counted. When IF-derived conditioned
medium was added, the number of migrated cells greatly
increased. However, the addition of anti-TGF-a and anti-TGF-b1
antibodies inhibited migration of GB-d1 cells: the inhibitory effect
of anti-TGF-b1 antibody was more potent than that of anti-TGF-a
(Figure 2E). These results indicate that IF cells do secrete cell
motility factors, which proved to be TGF-a and TGF-b1.
Autocrine regulation of IF cell motility by TGF-b1 and
TGF-a
Based on the finding that IF cells secreted TGF-a and TGF-b1 as
cell motility factors, we analysed the regulation of IF cell motility
by TGF-a, TGF-b1 and HGF, using Transwell assay. When
TGF-a, TGF-b1 and HGF were individually added to culture of IF
cells the migration of IF cells was dose-dependently stimulated by
these growth factors (Figure 3A). Although a significant number
of IF cells migrated through the membrane in control culture,
migration of IF cells was further stimulated by these growth
factors, in a dose-dependent manner. The potential to stimulate
migration of IF cells was HGF > TGF-a > TGF-b1. HGF was
most potent in stimulating IF cell motility and fivefold enhance-
ment was seen with 10 ng ml–1 HGF. We also examined effects of
these growth factors on proliferation of IF cells (Figure 3B). When
the cells were cultured in the absence or presence of growth factors
for 72 h, both TGF-a and HGF weakly stimulated the proliferation
of IF cells, whereas TGF-b1 inhibited IF cell proliferation; there-
fore HGF and TGF-a are weak mitogens while TGF-b1 inhibits
growth of IF cells.
To observe if the motility of IF cells was regulated by these
factors in an autocrine manner, effects of antibodies on
autonomous migration of IF cells were tested, using Transwell
assay (Figure 4). When antibodies against TGF-a and TGF-b1
were added, migration of IF cells was inhibited to 49% and 33% of
the control culture respectively. Simultaneous addition of these
antibodies inhibited migration of IF cells to lower levels than seen
in cases of anti-TGF-b1 or anti-TGF-a antibody alone. However,
anti-HGF antibody had no significant effect on the autonomous
migration of IF cells. Consistent with this, HGF was not detected
in conditioned medium of IF cells by ELISA (not shown).
Therefore, although TGF-a, TGF-b1 and HGF stimulate migra-
tion of IF cells, TGF-a and TGF-b, but not HGF, act as autocrine
cell motility factors which regulate their own cell motility.
Induction of fibroblast production of HGF by IF-derived
factor
Although IF cells do not produce HGF and HGF does not act as an
autocrine motility factor in IF cells, we speculated that stromal
fibroblasts-derived HGF might affect migration of IF cells in a
paracrine manner. We previously showed that several types of
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Figure 4 Effects of antibodies on autonomous migration of IF cells.
Migration of IF cells was measured using Transwell chamber and antibodies
(IgGs) against TGF-a, TGF-b1 and HGF (a-TGF-a, a-TGF-b1, a-HGF) were
added at 10 mg ml–1
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Figure 5 Enhancement of HGF production in human skin fibroblasts by
IF-derived conditioned medium (A) and its inhibition by IL-1 receptor
antagonist (B). Human skin fibroblasts were cultured in the absence or
presence of IF-derived conditioned medium or 1 ng ml-1 IL-1b and HGF
production during 24-h culture of the fibroblasts was measured (A).
IF-derived conditioned medium was added at 10% (v/v) to cultures of
fibroblasts and various concentrations of IL-1 receptor antagonist (IL-1RA)
were added (B)Autocrine/paracrine regulation in oral cancer 1713
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carcinoma cells secrete inducing factors for HGF production in
normal human fibroblasts (Matsumoto et al, 1996; Nakamura et al,
1997). We therefore examined if IF cells would produce an
inducing factor for HGF production in normal human fibroblasts
derived from dermal tissue. When IF-derived conditioned medium
was added to culture of human fibroblasts, HGF production by
fibroblasts was dose-dependently stimulated and the maximal
stimulatory effect by 4.4-fold was comparable to that seen with
1 ng ml–1 IL-1b (Figure 5A). Therefore, IF cells secrete a potent
inducing factor for HGF production in fibroblasts.
To identify the IF-derived inducing factor for HGF production,
we tested effects of antibodies and antagonistic molecules for
inducers of HGF production in fibroblasts, including anti-bFGF,
anti-PDGF and an IL-1 receptor antagonist. Addition of an IL-1
receptor antagonist suppressed the inducing activity in IF-derived
conditioned medium to close to basal level (Figure 5B), whereas
anti-bFGF and anti-PDGF antibodies had no significant effect on
HGF-inducing activity in IF-derived conditioned medium (not
shown). This finding indicates that IF cells secrete IL-1 (IL-1a,
IL-1b1 or both) as an HGF inducer for stromal fibroblast. Similar
results were obtained when fibroblasts derived from oral stromal
tissue were used, while IL-1b was less potent in stimulating HGF
production than that seen with skin fibroblasts (not shown).
Regulation of IF tumour invasiveness
Our findings indicate that motility of IF cells is regulated by at
least three distinct growth factors: TGF-a and TGF-b1 act as
autocrine motility factors, while HGF may act as a paracrine
motility factor derived from stromal fibroblasts. We then asked
whether the invasiveness of IF cells is regulated by these autocrine
and paracrine motility factors. IF tumour cells were seeded on
Matrigel invasion chamber and cultured for 48 h in the absence or
presence of TGF-a, TGF-b1 or HGF (Figure 6). In this apparatus,
invasive cells degrade Matrigel extracellular matrix components
and then migrate to the undersurface of the membrane. During
48-h culture, a few cells invaded through Matrigel components
and a filter membrane in the absence of growth factors. When IF
cells were cultured in the presence of HGF, the number of invaded
cells greatly increased: fourfold enhancement by HGF. However,
both TGF-a and TGF-b1 weakly stimulated invasion of IF cells
and their potency in stimulating invasion of IF cells was much less
than that of HGF. On the other hand, addition of conditioned
medium from human oral stromal fibroblasts also stimulated the
invasion of IF cells. The stimulatory effect by this medium was
little inhibited by antibodies against TGF-a and TGF-b1 but was
greatly suppressed by anti-HGF antibody.
We next analysed invasiveness of IF tumour cells cultured in
collagen gel matrix (Figure 7). When IF cells were grown in
collagen gel matrix for 6 days in the absence of growth factors,
they grew in a cystic structure with no invasive characteristics
(Figure 7A, G). In contrast, when the cells were grown in the pres-
ence of HGF, they showed invasive and some characteristics of
scattering (Figure 7D). Transverse section of these cells showed
that IF cells lost cell–cell contact and several cells invaded the
collagen gel matrix (Figure 7H). Similarly, the addition of condi-
tioned medium from human oral stromal fibroblasts to cultures of
IF cells induced significant invasive characteristics (Figure 7E). In
contrast, addition of TGF-a or TGF-b1 did not induce invasive
characteristics in IF cells grown in collagen gels (Figure 7B, C).
Importantly, the invasive phenotype induced by fibroblast-derived
conditioned medium was almost completely prevented by anti-
HGF antibody (Figure 7F), but not by anti-TGF-a and anti-TGF-
b1 antibodies (not shown). These observations mean that the
invasiveness of IF cells is potently stimulated by HGF, but only
marginally so by TGF-a and TGF-b1.
DISCUSSION
Malignant tumours are characterized by unrestrained growth and
invasion into surrounding host tissue. Tumour invasion involves
the active locomotion of tumour cells into and through host tissue
barriers. Various polypeptide growth factors such as epidermal
growth factor, PDGF, TGF-a, TGF-b1 and HGF stimulate not
only cell proliferation but also chemotactic migration of various
types of tumour cells. Likewise, a few classes of proteins which
predominantly stimulate the motility of cells have been identified,
using assay systems that measure cell motility (Stoker and
Gherardi, 1991; Levine et al, 1995; Silletti and Raz, 1996). It is
reasonable to consider that these motility factors are responsible
for the highly motile behaviour in invasive tumour cells. Using
human oral squamous carcinoma cell line, we analysed the
regulation of cellular motility and invasiveness by extracellularly
acting proteins produced by tumour cells themselves and stromal
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fibroblasts. We identified TGF-a and TGF-b1 to be autocrine-
acting motility factors, and HGF to be a stromal-derived paracrine
motility factor in IF oral squamous carcinoma cells (Figure 8).
Importantly, the invasiveness of IF cells was potently stimulated
by HGF, but not by TGF-a and TGF-b1.
TGF-a and TGF-b1 were originally identified as tumour-
derived factors which confer anchorage-independent tumour
growth, while subsequent studies showed that TGF-a and TGF-b1
are produced in a wide variety of tumour cells and regulate their
own growth and motility (Derynck et al, 1987; Sporn et al, 1987;
Wright et al, 1993; Wright and Huang, 1996). Several investigators
noted that TGF-b1 stimulates migration and invasion of distinct
types of tumour cells, through an autocrine or a paracrine manner
(Welch et al, 1990; Mooradian et al, 1992; Wright et al, 1993;
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Figure 7 Invasive growth of IF cells in collagen gel matrix. IF cells were cultured for 7 days in the absence (A, G) or presence of TGF-a (B), TGF-b1 (C), HGF
(D, H), conditioned medium (CM) from oral stromal fibroblasts (E), or fibroblast-derived CM + anti-HGF IgG (F). Anti-HGF IgG was added at 10 mg ml–1.
Appearances of IF cells (A–F) and transverse sections (G, H) were shownAutocrine/paracrine regulation in oral cancer 1715
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Wright and Huang, 1996; Chicoine and Silbergeld, 1997; Inoue
et al, 1997). Likewise, TGF-a stimulates migration and invasion
of certain types of tumour cells such as endometrial adenocarci-
noma, glioma and uterine cervical carcinoma cells (Ueda et al,
1996, 1997; El Obeid et al, 1997). We identified motility factors
derived from IF oral squamous cell carcinoma cells as TGF-a and
TGF-b1. Since autonomous migration of IF cells was significantly
inhibited by antibodies against TGF-a and TGF-b1, these growth
factors may play a role as autocrine-acting cell motility factors
which stimulate self migration in IF oral carcinoma cells. On the
other hand, HGF stimulates the motility of a diversity of cells,
including normal epithelial cells, endothelial cells and a wide
variety of tumour cells (reviewed in Jiang et al, 1993, 1998;
Zarnegar and Michalopoulas, 1995; Matsumoto et al, 1997). It is
noteworthy that, although the motility of IF cells is enhanced by
TGF-a, TGF-b1 and HGF, invasion of IF cells is particularly regu-
lated by HGF rather than by TGF-a and TGF-b1. Similarly, we
previously noted that the invasiveness of GB-d1 gallbladder
cancer cells is potently stimulated by HGF but not TGF-a and
TGF-b1, while TGF-a and TGF-b1 both stimulate migration of
the cells (Matsumoto et al, 1996). Therefore, cellular responsive-
ness to stimulatory effects of TGF-a and TGF-b1 on invasion of
cancer cells seems to be cell type-dependent. Nevertheless, we
speculate that the production of TGF-a and TGF-b1 and autocrine
activation of their receptors may be involved in invasive and
metastatic behaviour in IF cells. Coexistence of TGF-a and TGF-
b1 supports anchorage-independent growth in cancer cells
(Derynck et al, 1987; Sporn et al, 1987), which is likely to increase
metastatic potential. Enhancement of tumour migration by TGF-a
and TGF-b1 may possibly increase invasiveness in IF cells, in
collaboration with stromal-derived HGF.
Invasiveness of tumour cells involves disruption of cell–cell
adhesion, enhanced cycle of detachment and attachment of
cell–substrate interaction, breakdown of extracellular matrix
components and enhanced cell motility. HGF induces tyrosine
phosphorylation of b-catenin (Watabe et al, 1993; Shibamoto et al,
1994; Hiscox and Jiang, 1999) and focal adhesion kinase
(Matsumoto et al, 1994). HGF activates Rho small GTP-binding
protein (Takaishi et al, 1994; Ridly et al, 1995), by which intracel-
lular cytoskeletal rearrangement occurs. These events are likely to
lead to increased cell motility, dissociation of cell–cell interaction
and remodelling of cell–substrate interactions. In addition to these
events, HGF induces urokinase-type plasminogen activator  (uPA)
expression (Pepper et al, 1992; Jeffers et al, 1996; Bennett et al,
1997; Date et al, 1998) and stimulates the production of matrix
metalloproteinases (MMPs) (Dunsmore et al, 1996; Bennett et al,
1997; Date et al, 1998). Jeffers et al (1996) demonstrated that
induction of the uPA proteolysis network by HGF is coupled to
enhanced tumorigenicity and invasive and metastatic properties in
certain tumour cell lines. Since the induction and/or activation of
proteinases that break down extracellular matrix components seem
to be, at the least, critical for induction of invasive potential also in
IF tumour cells, we analysed changes in activities of uPA and
gelatinases (MMP-2 and MMP-9) in IF cells treated with TGF-a,
TGF-b1 or HGF. However, we could not find specific changes in
these proteinase activities that correlate to distinct potentials of
TGF-a, TGF-b1 and HGF to stimulate invasiveness of IF tumour
cells. Identification of extracellular matrix proteinases responsible
for the induction of invasiveness by HGF remains to be addressed.
Nevertheless, cooperative activation of multiple events driven by
cMet/HGF receptor activation seems to be a cause for particular
potency of HGF to stimulate the invasion of IF oral carcinoma
cells, as well as other tumour cells.
Several lines of studies indicate that the growth and invasive
potential of carcinoma cells are influenced through interaction
with host stromal cells (van den Hooff, 1988; Matsumoto et al,
1989; Camps et al, 1990; Wernert, 1997). Indeed, the in vitro
invasion of various human oral squamous carcinoma cells into
collagen gel matrix was specifically induced by co-cultivation
with stromal fibroblasts (Matsumoto et al, 1989) and the fibro-
blast-derived factor responsible for invasion of oral carcinoma
cells proved to be HGF (Matsumoto et al, 1994). Thus these earlier
findings apparently coincide with our present results: invasion of
IF oral squamous carcinoma cells is particularly stimulated by
stroma-derived HGF. Moreover, of interest in this study is that IF
cells secrete IL-1 as a potent inducer for production of HGF in
stromal fibroblasts. We reported that several types of carcinoma
cells secrete inducers for HGF production in fibroblasts and
fibroblast-derived HGF stimulates invasion of carcinoma cells.
IL-1, bFGF and PDGF were identified as tumour-derived HGF-
inducers (Matsumoto et al, 1996; Nakamura et al, 1997). There
may be mutual paracrine interactions between IF tumour cells and
fibroblasts: IL-1 derived from IF tumour cells activates neigh-
bouring fibroblasts to up-regulate HGF production, while fibro-
blast-derived HGF in turn affects invasion of IF cells (Figure 8).
Moreover, HGF has angiogenic activity (Bussolino et al, 1992;
Grant et al, 1993) and breast carcinoma cells capable of producing
HGF induced more extensive angiogenesis in vivo than that seen
in parental cells incapable of producing HGF (Lamszus et al,
1997). Taken together, HGF seems to increase invasive and angio-
genic characteristics in IF tumours through a paracrine interaction.
We used a newly established IF human oral squamous carci-
noma cell line which possesses highly invasive and metastatic
potentials, and identified distinct cells that affect motility and
invasiveness of tumour cells in an autocrine or paracrine fashion.
The utilization of multiple cell motility/invasion factors that act in
distinct pathways in IF oral squamous carcinoma cells may confer
highly invasive and metastatic potentials in microenvironments of
tumour. Finally, based on the finding that local interaction between
IF cells and fibroblasts, as mediated by HGF, is a mechanism
leading to even more invasive events, we propose that disruption
of this mutual interaction may be one strategy for prevention of
tumour invasion and metastasis. In this context, the application of
a newly identified four kringle containing antagonist for HGF
(Date et al, 1997, 1998) can be tested for potential therapeutic
value in suppressing invasion and metastasis of malignant oral
squamous carcinoma cells.
IL-1: HGF-inducer
Mesenchymal
fibroblasts
HGF: paracrine-acting
motility factor
TGFa,TGFb:
IF tumour cells
autocrine-acting
motility factor
Figure 8 A schematic representation of the regulation of the IF tumour
invasion by autocrine- and paracrine-acting factors. TGF-a and TGF-b1 act
as autocrine-acting motility factors, while HGF acts as fibroblast-derived
paracrine-acting motility factor. IF cells secrete IL-1 as an inducer for HGF
production in fibroblasts1716 R Hasina et al
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